• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

181.70 +4.47 (+2.52%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,460,472
Open 179.32
Bid (Size) 136.53 (100)
Ask (Size) 190.91 (100)
Prev. Close 177.23
Today's Range 178.00 - 186.52
52wk Range 100.99 - 198.87
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Healthcare Stocks That Concern Us
October 02, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be... 
Via StockStory
News headline image
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead
September 09, 2026
Over the past six months, Repligen has been a great trade, beating the S&P 500 by 18.1%. Its stock price has climbed to $168.43, representing a healthy 31.7%... 
Via StockStory
Topics Stocks

Performance

52-Week Range 8.6% below 52-week high
181.70
100.9952W Low 198.8752W High
1 Week 8.6% below 1-week high
177.121W Low 198.871W High

Repligen Corporation - Common Stock (RGEN) traded between $100.99 and $198.87 over the past 52 weeks and last traded at $181.70, 8.6% below its 52-week high. Over the past week it ranged between $177.12 and $198.87.

Past 12 Months
-6.4%
+5.1%
+28.4%
+55.4%
+10.6%
+25.1%
1W -$12.39
1M +$8.76
3M +$40.24
6M +$64.75
YTD +$17.35
1Y +$36.47

RGEN was +25.1% over the past year, +55.4% over six months, +10.6% year to date, -6.4% in the last week.

12 Months vs Market
RGEN
+25.1%
DIA
+9.9%
SPY
+15.0%
QQQ
+23.7%
IWM
+15.4%

Over the past 12 months RGEN returned +25.1% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.

Volume & Liquidity 1.32× 3-mo avg
Today 1,460,472 3-mo avg 1.1M
1W
1.4M
1M
1.1M
3M
1.1M
6M
1.1M
YTD
1.0M
1Y
985.5K

RGEN most recently traded 1,460,472 shares against a 3-month average daily volume of 1.1M.

More News

Read More
Repligen Corp (NASDAQ:RGEN) Combines Strong Growth with a Constructive Technical Setup ↗
September 05, 2026
Via Chartmill
News headline image
1 Profitable Stock on Our Buy List and 2 We Brush Off
August 28, 2026
Via StockStory
News headline image
3 High-Flying Stocks with Warning Signs
August 24, 2026
Via StockStory
Topics Supply Chain
Repligen (NASDAQ:RGEN) Combines Strong Growth with a Promising Technical Breakout Setup ↗
July 30, 2026
Via Chartmill
Repligen (NASDAQ:RGEN) Rallies as Quality Stock Delivers Earnings Beat ↗
July 28, 2026
Via Chartmill
News headline image
3 Hyped Up Stocks We Keep Off Our Radar
August 21, 2026
Via StockStory
News headline image
Unpacking Q2 Earnings: Repligen (NASDAQ:RGEN) In The Context Of Other Drug Development Inputs & Services Stocks
August 16, 2026
Via StockStory
News headline image
2 Growth Stocks to Add to Your Roster and 1 We Avoid
August 13, 2026
Via StockStory
Topics Credit Cards
News headline image
Why Repligen (RGEN) Stock Is Up Today
July 28, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Repligen Q2 Earnings Call Highlights ↗
July 28, 2026
Via MarketBeat
Topics Earnings
Which stocks are gapping on Tuesday? ↗
July 28, 2026
Via Chartmill
News headline image
Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q2 CY2026
July 28, 2026
Via StockStory
News headline image
Repligen (RGEN) Q2 Earnings: What To Expect
July 26, 2026
Via StockStory
News headline image
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know
July 24, 2026
Via StockStory
News headline image
3 Cash-Producing Stocks That Concern Us
July 24, 2026
Via StockStory
News headline image
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach ↗
July 22, 2026
Via MarketBeat
News headline image
Why Repligen (RGEN) Stock Is Trading Lower Today
July 21, 2026
Via StockStory
News headline image
3 Reasons RGEN is Risky and 1 Stock to Buy Instead
July 08, 2026
Via StockStory
Topics Stocks Supply Chain
News headline image
2 High-Flying Stocks on Our Watchlist and 1 We Find Risky
June 25, 2026
Via StockStory
News headline image
2 Profitable Stocks on Our Watchlist and 1 Facing Challenges
June 19, 2026
Via StockStory
News headline image
3 Out-of-Favor Stocks We Keep Off Our Radar
May 22, 2026
Via StockStory
News headline image
Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks
May 18, 2026
Via StockStory
News headline image
Why Repligen (RGEN) Stock Is Trading Up Today
May 15, 2026
Via StockStory
Topics Artificial Intelligence Economy

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 181.70
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 10/02/26 04:00 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 10.12B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap